Publication | Closed Access

Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein—Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue

Diagnostic VirologyElevated Antibody TitersViral PersistenceNeurovirologyHuman Herpesvirus-6Epstein—barr VirusAntiviral TherapyVirologyHerpesvirusesNeurologyChronic Viral InfectionMedicineHerpes Simplex Virus Vaccines